Achieve Life Sciences

Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine dependence. The company focuses on addressing the global smoking health epidemic through the development and commercialization of cytisinicline.

Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine dependence. The company focuses on addressing the global smoking health epidemic through the development and commercialization of cytisinicline.

• cytisinicline

• 2021-06-03

  U.S. patent applications covering cytisinicline dosing regimen allowed[4]美国批准涵盖胞嘧啶碱给药方案的专利申请finance.yahoo.com

  Reported: 2021-06-03

  Achieve Life Sciences announced that the U.S. Patent and Trademark Office had allowed two patent applications covering a 3.0 mg three-times-daily cytisinicline dosing regimen.

• 2021-05-25

  Achieve Life Sciences prices $20 million public offering[5]Achieve Life Sciences为2,000万美元公开发行定价memphissun.com

  Achieve Life Sciences announced pricing for an underwritten public offering of 2,857,143 common shares at $7.00 per share. The offering was expected to close on or about May 27, 2021, subject to customary closing conditions.

• 2019-12-17

  Achieve Life Sciences prices a $12 million public offering[6]Achieve Life Sciences确定1,200万美元公开发行定价prnewswire.com

  Reported: 2019-12-17

  Achieve Life Sciences announced the pricing of an underwritten public offering of units expected to generate $12 million in gross proceeds. The offering was expected to close on December 19, 2019, subject to customary closing conditions.

• 2019-11-06

  Achieve reports third-quarter 2019 financial results[7]Achieve公布2019年第三季度财务业绩prnewswire.com

  Reported: 2019-11-06

  Achieve Life Sciences announced its third-quarter 2019 financial results, reporting a net loss of $3.7 million for the quarter.

1. 1Home | Achieve Life Sciencesachievelifesciences.com
2. 2About | Achieve Life Sciencesachievelifesciences.com
3. 3Products | Achieve Life Sciencesachievelifesciences.com
4. 4美国批准涵盖胞嘧啶碱给药方案的专利申请finance.yahoo.com
5. 5Achieve Life Sciences为2,000万美元公开发行定价memphissun.com
6. 6Achieve Life Sciences确定1,200万美元公开发行定价prnewswire.com
7. 7Achieve公布2019年第三季度财务业绩prnewswire.com
8. 8Achieve Life Sciences, Inc.: Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate Updatefinanznachrichten.de
9. 9Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Programprnewswire.com